NCT06768177View on ClinicalTrials.gov

Platelet Rich Plasma (PRP) as Terapeutical Option in Erectil Disfunction (DE)

NAEnrolling by invitationINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2025

Conditions
Erectile Dysfunction Due to General Medical ConditionErectile Dysfunction Following Radical ProstatectomyErectile Dysfunction Associated With Type 2 Diabetes MellitusErectile Dysfunctions
Interventions
DRUG

PRP injection

3 ML OF PRP

DRUG

Alprostadil 20 micrograms

1 ML

Trial Locations (1)

70124

Policlinico di Bari - Azienda Ospedaliero Universitaria Consorziale Policlinico, Bari

All Listed Sponsors
lead

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

OTHER